Xeris Pharmaceuticals Inc. (XERS) Reports In-Line Q2 EPS ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| (NASDAQ: XERS) | Delayed: 10.71 -0.04 (0.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.75 | 52 Week High | $ | |||
| Open | $10.81 | 52 Week Low | $ | |||
| Day High | $10.88 | P/E | N/A | |||
| Day Low | $10.52 | EPS | $ | |||
| Volume | 1,545,589 | |||||
